has received honoraria from Boehringer Ingelheim, Eli Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, AbbVie, Janssen, Bayer, Prometic, Bristol Myers Squibb, Maze, Gilead, CSL-Behring, Otsuka, Novartis, Youngene and Novo Nordisk and has received operational funding for clinical trials from Boehringer Ingelheim, Eli Lilly, Merck, Janssen, Sanofi, AstraZeneca, CSL-Behring and Novo Nordisk
The future is choice, but not casual choice The market is moving towards more oral options
It works with your biology rather than overriding it
Her practice combines evidence-based medicine with attentive, longitudinal care from everyday checkups and sick visits to weight loss, hormone health, and aesthetic wellness
So: Should You Use a GLP-1 Agent for Dementia Prevention